Atlas Trials

Safety and Immunogenicity Study of 3 Vaccinations With TICOVAC in 2 Dosages in Healthy Children Aged Between 6 Months and 3 Years

Clinical trial NCT00161746 · COMPLETED

Trial details

NCT number
NCT00161746
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Encephalitis, Tick-borne
Start date
1998-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.